“GLP-1 Therapies Enter the CKM Guideline For the First Time, GLP-1-Based Therapy Is Recommended to Reduce Cardiac Events”. Diabzen 4, no. 18 (July 7, 2026): 36–37. Accessed September 17, 2026. https://www.thediabzen.com/index.php/d/article/view/61.